Unknown

Dataset Information

0

Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study.

ABSTRACT:

SUBMITTER: Lozano-Rodriguez R 

PROVIDER: S-EPMC9092002 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan.
| S-EPMC9705976 | biostudies-literature
Unknown Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia.
| S-EPMC8585611 | biostudies-literature
Unknown Prior human endemic coronavirus exposure does not affect humoral responses to SARS-CoV-2 protein vaccines.
| S-EPMC12256584 | biostudies-literature
Unknown Overview of approved and upcoming vaccines for SARS-CoV-2: a living review.
| S-EPMC8194545 | biostudies-literature
Unknown Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study.
| S-EPMC9918183 | biostudies-literature
Unknown Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
| S-EPMC9113667 | biostudies-literature
Unknown Mixed formulation of mRNA and protein-based COVID-19 vaccines triggered superior neutralizing antibody responses.
| S-EPMC9717706 | biostudies-literature
Unknown Review on Approved and Inprogress COVID-19 Vaccines.
| S-EPMC9420219 | biostudies-literature
Unknown Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants.
| S-EPMC7971202 | biostudies-literature
Unknown Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer's Disease.
| S-EPMC8571023 | biostudies-literature